Press releases

Reaching new heights

Reaching new heights

Case Study Origenis GmbH: With Small Molecules against Neurodegenerative Diseases

September 03, 2019 Mithilfe ihrer KI-basierten Small Molecules Technologie schafften es Michael Almstetter und seine zwei Mitstreiter...

Origenis GmbH Announces Research Collaboration with U.S. Cancer Center

June 04, 2019 Origenis AI Discovery Platform to Identify and Optimize Small Molecule Preclinical Development Candidates for Glioblastoma...

Gateway to Biotech: Top researchers met industry experts in the Faculty Club at IZB

May 16, 2019 Michael Almstetter, CEO Origenis GmbH, explained what can be learned from progress in oncology in order to develop new...